Published in PLoS Negl Trop Dis on August 29, 2013
Dynamics of the emergence and establishment of a newly dominant genotype of Japanese encephalitis virus throughout Asia. J Virol (2014) 0.98
Reconstruction of the Evolutionary History and Dispersal of Usutu Virus, a Neglected Emerging Arbovirus in Europe and Africa. MBio (2016) 0.94
Comparison of genotypes I and III in Japanese encephalitis virus reveals distinct differences in their genetic and host diversity. J Virol (2014) 0.89
Molecular epidemiology of Japanese encephalitis virus in mosquitoes in Taiwan during 2005-2012. PLoS Negl Trop Dis (2014) 0.88
Vector-free transmission and persistence of Japanese encephalitis virus in pigs. Nat Commun (2016) 0.86
A Japanese encephalitis virus genotype 5 molecular clone is highly neuropathogenic in a mouse model: impact of the structural protein region on virulence. J Virol (2015) 0.85
Japanese encephalitis vaccines: Immunogenicity, protective efficacy, effectiveness, and impact on the burden of disease. Hum Vaccin Immunother (2017) 0.82
Fluid Spatial Dynamics of West Nile Virus in the United States: Rapid Spread in a Permissive Host Environment. J Virol (2015) 0.79
A Lentiviral Vector Expressing Japanese Encephalitis Virus-like Particles Elicits Broad Neutralizing Antibody Response in Pigs. PLoS Negl Trop Dis (2015) 0.77
Emergence or improved detection of Japanese encephalitis virus in the Himalayan highlands? Trans R Soc Trop Med Hyg (2016) 0.76
European Aedes albopictus and Culex pipiens are Competent Vectors for Japanese Encephalitis Virus. PLoS Negl Trop Dis (2017) 0.75
Comparison of the antigenic relationship between Japanese encephalitis virus genotypes 1 and 3. Clin Exp Vaccine Res (2016) 0.75
The Molecular Epidemiology and Evolution of Murray Valley Encephalitis Virus: Recent Emergence of Distinct Sub-lineages of the Dominant Genotype 1. PLoS Negl Trop Dis (2015) 0.75
Differential Infectivities among Different Japanese Encephalitis Virus Genotypes in Culex quinquefasciatus Mosquitoes. PLoS Negl Trop Dis (2016) 0.75
Neutralization of Japanese Encephalitis Virus by heme-induced broadly reactive human monoclonal antibody. Sci Rep (2015) 0.75
Inference of Japanese encephalitis virus ecological and evolutionary dynamics from passive and active virus surveillance. Virus Evol (2016) 0.75
BEAST: Bayesian evolutionary analysis by sampling trees. BMC Evol Biol (2007) 74.13
New algorithms and methods to estimate maximum-likelihood phylogenies: assessing the performance of PhyML 3.0. Syst Biol (2010) 53.37
SeaView version 4: A multiplatform graphical user interface for sequence alignment and phylogenetic tree building. Mol Biol Evol (2009) 21.24
Bayesian coalescent inference of past population dynamics from molecular sequences. Mol Biol Evol (2005) 18.57
Origin of the West Nile virus responsible for an outbreak of encephalitis in the northeastern United States. Science (1999) 18.55
HyPhy: hypothesis testing using phylogenies. Bioinformatics (2004) 17.33
Flavivirus genome organization, expression, and replication. Annu Rev Microbiol (1990) 14.20
The envelope glycoprotein from tick-borne encephalitis virus at 2 A resolution. Nature (1995) 12.25
Bayesian phylogeography finds its roots. PLoS Comput Biol (2009) 10.99
Analyzing the mosaic structure of genes. J Mol Evol (1992) 10.99
Not so different after all: a comparison of methods for detecting amino acid sites under selection. Mol Biol Evol (2005) 10.21
Bayesian selection of continuous-time Markov chain evolutionary models. Mol Biol Evol (2001) 8.69
Datamonkey: rapid detection of selective pressure on individual sites of codon alignments. Bioinformatics (2005) 8.62
Choosing appropriate substitution models for the phylogenetic analysis of protein-coding sequences. Mol Biol Evol (2005) 8.42
RDP2: recombination detection and analysis from sequence alignments. Bioinformatics (2004) 7.29
RDP: detection of recombination amongst aligned sequences. Bioinformatics (2000) 6.83
Evaluation of methods for detecting recombination from DNA sequences: computer simulations. Proc Natl Acad Sci U S A (2001) 6.72
Possible emergence of new geminiviruses by frequent recombination. Virology (1999) 5.74
Rates of molecular evolution in RNA viruses: a quantitative phylogenetic analysis. J Mol Evol (2002) 5.24
A modified bootscan algorithm for automated identification of recombinant sequences and recombination breakpoints. AIDS Res Hum Retroviruses (2005) 4.21
Correlating viral phenotypes with phylogeny: accounting for phylogenetic uncertainty. Infect Genet Evol (2007) 4.11
Origin and evolution of Japanese encephalitis virus in southeast Asia. J Virol (2003) 3.92
Estimated global incidence of Japanese encephalitis: a systematic review. Bull World Health Organ (2011) 3.35
Emergence of Usutu virus, an African mosquito-borne flavivirus of the Japanese encephalitis virus group, central Europe. Emerg Infect Dis (2002) 2.88
Molecular epidemiological analysis of Japanese encephalitis virus in China. J Gen Virol (2007) 2.28
An outbreak of Japanese encephalitis in the Torres Strait, Australia, 1995. Med J Aust (1996) 2.25
Shift in Japanese encephalitis virus (JEV) genotype circulating in northern Vietnam: implications for frequent introductions of JEV from Southeast Asia to East Asia. J Gen Virol (2004) 2.21
AIR: A batch-oriented web program package for construction of supermatrices ready for phylogenomic analyses. BMC Bioinformatics (2009) 2.17
Accurate model selection of relaxed molecular clocks in bayesian phylogenetics. Mol Biol Evol (2012) 2.13
Complete genome analysis and molecular characterization of Usutu virus that emerged in Austria in 2001: comparison with the South African strain SAAR-1776 and other flaviviruses. Virology (2004) 1.98
A maximum likelihood method for detecting directional evolution in protein sequences and its application to influenza A virus. Mol Biol Evol (2008) 1.96
Phylogeography of West Nile virus: from the cradle of evolution in Africa to Eurasia, Australia, and the Americas. J Virol (2010) 1.88
Phylogenetic analysis of Japanese encephalitis virus: envelope gene based analysis reveals a fifth genotype, geographic clustering, and multiple introductions of the virus into the Indian subcontinent. Am J Trop Med Hyg (2001) 1.78
Genetic variation of Japanese encephalitis virus in nature. J Gen Virol (1990) 1.75
The natural history of Japanese encephalitis virus. Annu Rev Microbiol (1986) 1.70
Genotype v Japanese encephalitis virus is emerging. PLoS Negl Trop Dis (2011) 1.62
Out of Africa: a molecular perspective on the introduction of yellow fever virus into the Americas. PLoS Pathog (2007) 1.60
Japanese B encephalitis virus in the blood of experimentally inoculated birds; epidemiological implications. Am J Hyg (1951) 1.57
Change in Japanese encephalitis virus distribution, Thailand. Emerg Infect Dis (2008) 1.55
Short report: a major genotype of Japanese encephalitis virus currently circulating in Japan. Am J Trop Med Hyg (2003) 1.51
A new genotype of Japanese encephalitis virus from Indonesia. Am J Trop Med Hyg (1992) 1.48
Emergence of genotype I of Japanese encephalitis virus as the dominant genotype in Asia. J Virol (2011) 1.46
Emergence of Japanese encephalitis virus genotype V in the Republic of Korea. Virol J (2011) 1.35
Molecular phylogenetic and evolutionary analyses of Muar strain of Japanese encephalitis virus reveal it is the missing fifth genotype. Infect Genet Evol (2011) 1.33
Detection of west Nile and Japanese encephalitis viral genome sequences in cerebrospinal fluid from acute encephalitis cases in Karachi, Pakistan. Microbiol Immunol (1994) 1.29
Ecologic studies of Japanese encephalitis virus in Japan. IX. Epidemiologic correlations and conclusions. Am J Trop Med Hyg (1959) 1.27
Japanese encephalitis, Tibet, China. Emerg Infect Dis (2011) 1.26
Ecologic studies of Japanese encephalitis virus in Japan. II. Mosquito infection. Am J Trop Med Hyg (1959) 1.24
Virus infections in bats. Monogr Virol (1974) 1.15
Introduction of Japanese encephalitis virus genotype I, India. Emerg Infect Dis (2011) 1.13
Yellow fever virus maintenance in Trinidad and its dispersal throughout the Americas. J Virol (2010) 1.09
Outbreak of Japanese encephalitis on the island of Saipan, 1990. J Infect Dis (1993) 1.08
Ecologic studies of Japanese encephalitis virus in Japan. V. Avian factors. Am J Trop Med Hyg (1959) 1.05
Japanese encephalitis viruses from bats in Yunnan, China. Emerg Infect Dis (2009) 1.04
Japanese B encephalitis in American soldiers in Korea. Am J Hyg (1947) 1.03
Japanese encephalitis virus genotype replacement, Taiwan, 2009-2010. Emerg Infect Dis (2011) 0.98
Ecologic studies of Japanese encephalitis virus in Japan. III. Mosquito factors. Zootropism and vertical flight of Culex tritaeniorhynchus with observations on variations in collections from animal-baited traps in different habitats. Am J Trop Med Hyg (1959) 0.96
Genetic characterization of early isolates of Japanese encephalitis virus: genotype II has been circulating since at least 1951. J Gen Virol (2009) 0.96
Experimental vertical transmission of Japanese encephalitis virus by Culex tritaeniorhynchus and other mosquitoes. Am J Trop Med Hyg (1989) 0.94
Studies on Japanese encephalitis virus infection of reptiles. I. Experimental infection of snakes and lizards. Jpn J Exp Med (1983) 0.92
Ecologic studies of Japanese encephalitis firus in Japan. I. Introduction. Am J Trop Med Hyg (1959) 0.91
Antigenic analysis of Japanese encephalitis virus by using monoclonal antibodies. Infect Immun (1984) 0.90
Ecologic studies of Japanese encephalitis virus in Japan. IV. Avian infection. Am J Trop Med Hyg (1959) 0.90
Japanese B encephalitis; clinical observations in an outbreak on Okinawa Shima. Arch Neurol Psychiatry (1947) 0.89
Envelope gene sequence variation among Japanese encephalitis viruses isolated in Korea. Acta Virol (1997) 0.87
Immunologic studies of Japanese encephalitis virus in Japan. III. Infection and antibody responses of birds. J Immunol (1959) 0.87
Genetic diversity of Japanese encephalitis virus isolates obtained from the Indonesian archipelago between 1974 and 1987. Vector Borne Zoonotic Dis (2013) 0.85
Genotypes of Japanese encephalitis virus isolated in three states in Malaysia. Am J Trop Med Hyg (1997) 0.84
Genetic characterization of Japanese encephalitis virus genotype II strains isolated from 1951 to 1978. J Gen Virol (2010) 0.83
The transmission of Japanese B encephalitis by mosquitoes after experimental hibernation. Am J Hyg (1950) 0.81
Transovarial transmission of Japanese encephalitis virus by Culex tritaeniorhynchus mosquitoes. Am J Trop Med Hyg (1980) 0.81
Immunologic studies of Japanese encephalitis virus in Japan. IV. Maternal antibody in birds. J Immunol (1959) 0.78
Studies of arthropod-borne virus infections in chiroptera. VI. Isolation of Japanese B encephalitis virus from naturally infected bats. Am J Trop Med Hyg (1970) 0.77
Transmission cycles, host range, evolution and emergence of arboviral disease. Nat Rev Microbiol (2004) 4.13
Origin and evolution of Japanese encephalitis virus in southeast Asia. J Virol (2003) 3.92
West Nile virus: where are we now? Lancet Infect Dis (2004) 3.49
Phylogenetic analysis of North American West Nile virus isolates, 2001-2004: evidence for the emergence of a dominant genotype. Virology (2005) 3.14
Mouse neuroinvasive phenotype of West Nile virus strains varies depending upon virus genotype. Virology (2002) 2.96
Identification of neutralizing epitopes within structural domain III of the West Nile virus envelope protein. J Virol (2002) 2.66
Limited evolution of West Nile virus has occurred during its southwesterly spread in the United States. Virology (2003) 2.59
Envelope protein glycosylation status influences mouse neuroinvasion phenotype of genetic lineage 1 West Nile virus strains. J Virol (2005) 2.52
Adaptation to different human populations by HIV-1 revealed by codon-based analyses. PLoS Comput Biol (2006) 2.48
Characterization of an antigenic site that contains a dominant, type-specific neutralization determinant on the envelope protein domain III (ED3) of dengue 2 virus. Virology (2007) 2.40
West Nile virus in Mexico: evidence of widespread circulation since July 2002. Emerg Infect Dis (2003) 2.27
Phylodynamics of infectious disease epidemics. Genetics (2009) 2.15
Guidelines for Plaque-Reduction Neutralization Testing of Human Antibodies to Dengue Viruses. Viral Immunol (2008) 2.11
Characterization of dengue virus complex-specific neutralizing epitopes on envelope protein domain III of dengue 2 virus. J Virol (2008) 1.98
Phylogeography of West Nile virus: from the cradle of evolution in Africa to Eurasia, Australia, and the Americas. J Virol (2010) 1.88
Human immunodeficiency virus type 1 clade B superinfection: evidence for differential immune containment of distinct clade B strains. J Virol (2005) 1.77
Emergence of attenuated West Nile virus variants in Texas, 2003. Virology (2004) 1.75
Genome sequence and attenuating mutations in West Nile virus isolate from Mexico. Emerg Infect Dis (2004) 1.73
Genetic variation among temporally and geographically distinct West Nile virus isolates, United States, 2001, 2002. Emerg Infect Dis (2003) 1.71
Solution structure and antibody binding studies of the envelope protein domain III from the New York strain of West Nile virus. J Biol Chem (2004) 1.66
Introductions of West Nile virus strains to Mexico. Emerg Infect Dis (2006) 1.61
Genetic divergence and dispersal of yellow fever virus, Brazil. Emerg Infect Dis (2004) 1.60
Out of Africa: a molecular perspective on the introduction of yellow fever virus into the Americas. PLoS Pathog (2007) 1.60
A single amino acid substitution in the central portion of the West Nile virus NS4B protein confers a highly attenuated phenotype in mice. Virology (2006) 1.54
Comparison of the live attenuated yellow fever vaccine 17D-204 strain to its virulent parental strain Asibi by deep sequencing. J Infect Dis (2013) 1.51
Simple epidemiological dynamics explain phylogenetic clustering of HIV from patients with recent infection. PLoS Comput Biol (2012) 1.51
Automated analysis of phylogenetic clusters. BMC Bioinformatics (2013) 1.38
West Nile Virus isolation in human and mosquitoes, Mexico. Emerg Infect Dis (2005) 1.32
Flavivirus-induced antibody cross-reactivity. J Gen Virol (2011) 1.28
Passive immunization with Tau oligomer monoclonal antibody reverses tauopathy phenotypes without affecting hyperphosphorylated neurofibrillary tangles. J Neurosci (2014) 1.28
Solution structure of the envelope protein domain III of dengue-4 virus. Virology (2007) 1.27
Differential expression of domain III neutralizing epitopes on the envelope proteins of West Nile virus strains. Virology (2005) 1.26
Experimental infection of rhesus macaques with West Nile virus: level and duration of viremia and kinetics of the antibody response after infection. J Infect Dis (2004) 1.25
Evolution of new genotype of West Nile virus in North America. Emerg Infect Dis (2011) 1.20
Viral dynamics during structured treatment interruptions of chronic human immunodeficiency virus type 1 infection. J Virol (2002) 1.15
Zika Virus: Diagnosis, Therapeutics, and Vaccine. ACS Infect Dis (2016) 1.15
A combination of naturally occurring mutations in North American West Nile virus nonstructural protein genes and in the 3' untranslated region alters virus phenotype. J Virol (2007) 1.14
Characterization of dengue complex-reactive epitopes on dengue 3 virus envelope protein domain III. Virology (2008) 1.13
Resurgence of West Nile neurologic disease in the United States in 2012: what happened? What needs to be done? Antiviral Res (2013) 1.13
Protection against Japanese encephalitis virus strains representing four genotypes by passive transfer of sera raised against ChimeriVax-JE experimental vaccine. Vaccine (2004) 1.11
Use of a recombinant envelope protein subunit antigen for specific serological diagnosis of West Nile virus infection. J Clin Microbiol (2004) 1.11
The enigma of yellow fever in East Africa. Rev Med Virol (2008) 1.09
A mutation in the envelope protein fusion loop attenuates mouse neuroinvasiveness of the NY99 strain of West Nile virus. Virology (2006) 1.08
Characterization of a viscerotropic yellow fever vaccine variant from a patient in Brazil. Vaccine (2006) 1.08
Solution structure and structural dynamics of envelope protein domain III of mosquito- and tick-borne flaviviruses. Biochemistry (2004) 1.07
HIV phylogenetics. BMJ (2007) 1.07
The epidemiology of yellow fever in Africa. Microbes Infect (2002) 1.06
Size heterogeneity in the 3' noncoding region of South American isolates of yellow fever virus. J Virol (2005) 1.06
Molecular evolution of lineage 2 West Nile virus. J Gen Virol (2012) 1.05
Mutations of an antibody binding energy hot spot on domain III of the dengue 2 envelope glycoprotein exploited for neutralization escape. Virology (2010) 1.05
Phenotypic hypersusceptibility to multiple protease inhibitors and low replicative capacity in patients who are chronically infected with human immunodeficiency virus type 1. J Virol (2005) 1.05
Use of recombinant E protein domain III-based enzyme-linked immunosorbent assays for differentiation of tick-borne encephalitis serocomplex flaviviruses from mosquito-borne flaviviruses. J Clin Microbiol (2004) 1.03
Scientific consultation on immunological correlates of protection induced by dengue vaccines report from a meeting held at the World Health Organization 17-18 November 2005. Vaccine (2007) 1.03
Development and characterization of non-glycosylated E and NS1 mutant viruses as a potential candidate vaccine for West Nile virus. Vaccine (2009) 1.03
Analysis of the complete genome of the tick-borne flavivirus Omsk hemorrhagic fever virus. Virology (2003) 1.02
Multiple amino acid changes at the first glycosylation motif in NS1 protein of West Nile virus are necessary for complete attenuation for mouse neuroinvasiveness. Vaccine (2011) 1.02
An animal model for the tickborne flavivirus--Omsk hemorrhagic fever virus. J Infect Dis (2004) 1.00
Molecular epidemiology and evolution of West Nile virus in North America. Int J Environ Res Public Health (2013) 0.99
Genetic variation of St. Louis encephalitis virus. J Gen Virol (2008) 0.98
Dynamics of the emergence and establishment of a newly dominant genotype of Japanese encephalitis virus throughout Asia. J Virol (2014) 0.98
Continued evolution of West Nile virus, Houston, Texas, USA, 2002-2012. Emerg Infect Dis (2013) 0.96
Genetic characterization of early isolates of Japanese encephalitis virus: genotype II has been circulating since at least 1951. J Gen Virol (2009) 0.96
Reduced avian virulence and viremia of West Nile virus isolates from Mexico and Texas. Am J Trop Med Hyg (2011) 0.95
Thioaptamer decoy targeting of AP-1 proteins influences cytokine expression and the outcome of arenavirus infections. J Gen Virol (2007) 0.95
Genome analysis and phylogenetic relationships between east, central and west African isolates of Yellow fever virus. J Gen Virol (2006) 0.95
Characterization of a dengue type-specific epitope on dengue 3 virus envelope protein domain III. J Gen Virol (2010) 0.95
Gene flow in environmental Legionella pneumophila leads to genetic and pathogenic heterogeneity within a Legionnaires' disease outbreak. Genome Biol (2014) 0.95
Role of BC loop residues in structure, function and antigenicity of the West Nile virus envelope protein receptor-binding domain III. Virology (2010) 0.94
Recombination and flavivirus vaccines: a commentary. Vaccine (2005) 0.94
Multiple pathways to the attenuation of West Nile virus in south-east Texas in 2003. Virology (2010) 0.93
Mutational analysis of the West Nile virus NS4B protein. Virology (2012) 0.92
Molecular characterization of a hamster viscerotropic strain of yellow fever virus. J Virol (2003) 0.92
Natural and nosocomial infection in a patient with West Nile encephalitis and extrapyramidal movement disorders. Clin Infect Dis (2003) 0.92
Short report: comparison of oral infectious dose of West Nile virus isolates representing three distinct genotypes in Culex quinquefasciatus. Am J Trop Med Hyg (2008) 0.92
Envelope and pre-membrane protein structural amino acid mutations mediate diminished avian growth and virulence of a Mexican West Nile virus isolate. J Gen Virol (2011) 0.91
Comparative phylogenies of yellow fever isolates from Peru and Brazil. FEMS Immunol Med Microbiol (2003) 0.89
Selection of thioaptamers for diagnostics and therapeutics. Ann N Y Acad Sci (2006) 0.89
Microbiology. Sources of antimicrobial resistance. Science (2013) 0.89
Dynamic transmission of West Nile virus across the United States-Mexican border. Virology (2012) 0.88
Complex adenovirus-mediated expression of West Nile virus C, PreM, E, and NS1 proteins induces both humoral and cellular immune responses. Clin Vaccine Immunol (2007) 0.88
Long range communication in the envelope protein domain III and its effect on the resistance of West Nile virus to antibody-mediated neutralization. J Biol Chem (2007) 0.88
Structure of yellow fever virus envelope protein domain III. Virology (2009) 0.87
Structure of the envelope protein domain III of Omsk hemorrhagic fever virus. Virology (2006) 0.87
A West Nile virus NS4B-P38G mutant strain induces adaptive immunity via TLR7-MyD88-dependent and independent signaling pathways. Vaccine (2013) 0.87
NMR assignments of the yellow fever virus envelope protein domain III. Biomol NMR Assign (2007) 0.85
Genetic diversity of Japanese encephalitis virus isolates obtained from the Indonesian archipelago between 1974 and 1987. Vector Borne Zoonotic Dis (2013) 0.85
Conservation of the DENV-2 type-specific and DEN complex-reactive antigenic sites among DENV-2 genotypes. Virology (2011) 0.85
Yellow fever virus infectivity for Bolivian Aedes aegypti mosquitoes. Emerg Infect Dis (2004) 0.84
Crystallization and preliminary X-ray diffraction analysis of Langat virus envelope protein domain III. Acta Crystallogr D Biol Crystallogr (2003) 0.84
Genetic characterization of Japanese encephalitis virus genotype II strains isolated from 1951 to 1978. J Gen Virol (2010) 0.83
Editorial commentary. Short-course oral corticosteroid therapy is not effective in early dengue infection. Clin Infect Dis (2012) 0.82
Comparative pathogenesis and systems biology for biodefense virus vaccine development. J Biomed Biotechnol (2010) 0.82
Current status and future prospects of yellow fever vaccines. Expert Rev Vaccines (2015) 0.81
NMR assignments of the sylvatic dengue 1 virus envelope protein domain III. Biomol NMR Assign (2008) 0.81
1H, 13C and 15N resonance assignments for domain III of the West Nile virus envelope protein. J Biomol NMR (2004) 0.80
NMR assignment of the dengue 4 virus envelope protein domain III. J Biomol NMR (2006) 0.80
Genetic basis of variation in tenofovir drug susceptibility in HIV-1. AIDS (2008) 0.80
Association of antiretroviral resistance genotypes with response to therapy--comparison of three models. Antivir Ther (2002) 0.80